Patrick Lamy
About Patrick Lamy
Patrick Lamy serves as the Senior Vice President of Commercial Strategy at Akero Therapeutics, a position he has held since 2023. With over 25 years of experience in commercial planning and strategy, he has previously worked at Iovance Biotherapeutics and Gilead Sciences in various leadership roles.
Work at Akero Therapeutics
Patrick Lamy serves as the Senior Vice President of Commercial Strategy at Akero Therapeutics. He has held this position since 2023, contributing to the company's strategic direction in commercial operations. His role involves overseeing the development and execution of commercial strategies to enhance the company's market presence.
Previous Experience at Iovance Biotherapeutics
Prior to his current role, Patrick Lamy worked at Iovance Biotherapeutics, Inc. as Vice President of Commercial from 2018 to 2021. During his tenure, he was responsible for leading commercial initiatives and strategies that supported the company's growth in the biotherapeutics sector.
Career at Gilead Sciences
Patrick Lamy has extensive experience at Gilead Sciences, where he held multiple senior roles. He served as Senior Director of Alliance Management from 2017 to 2018, and as Senior Director of US Payer Strategy and Marketing from 2015 to 2017. Additionally, he was Senior Director of Commercial Strategy for Liver Disease from 2012 to 2015 and Director of Commercial Strategy for Liver Disease from 2008 to 2012. His work at Gilead focused on commercial strategy and market access.
Education and Expertise
Patrick Lamy earned his Master of Business Administration (MBA) from the University of California, Berkeley, Haas School of Business. He also holds a Bachelor of Science in Biochemistry and Cellular Biology from UC San Diego. His educational background supports his over 25 years of experience in building commercial teams and leading global product launches in the biopharmaceutical industry.